SpheRx DBR III System differentiation is its ability to perform “instrument free” compression. Instrument free compression allows the spine surgeon to easily apply up to 5mm of compression by simply moving the DBR Guides with his hands.This elimination of the need for additional bulky or awkward instruments during compression in spinal fixation surgery is unmatched in the industry today. SpheRx(TM) DBR(TM) offers maximum overall simplicity of use, keeping with the Company’s philosophy of developing breakthrough products based on familiar spine surgery instrumentation.
Benefits:
- The product design allows for a simple, constrained rod insertion achieved through a dual ball rod with spherical ends, which are geometrically constrained within the DBR Guides during rod insertion, guiding the rod directly and easily into the heads of the pedicle screws.
- The spherical ends of the rod fit securely within the screws at both ends of the construct with no rod overhang, reducing the incidence of superior facet joint violation and tissue trauma. This unique, secure fit also provides the surgeon total confidence the rod is seated properly in the screws and eliminates the possibility of post-operative rod migration.
- SpheRx(TM) DBR(TM) is also designed to be seamlessly integrated with the Company’s NeuroVision(R) Nerve Avoidance System. Sequentially dilating insulators allow for dynamic stimulation and nerve monitoring during every step of the procedure, from K-Wire insertion and tapping, to screw insertion and compression.
- The NuVasive® SpheRx Spinal System consists of a series of polyaxial screws, fixed axis screws, rods, lock screws, hooks, and transverse connectors manufactured from Ti-6Al-4V per ASTM F-136 and ISO 5832-3.
About MIS
The trend in spine surgery for many procedures has been moving toward minimally invasive approaches. These include spine surgery for lumbar fusion, deformity surgery, cervical surgery and sacroiliac joint fusion. The benefits of minimally invasive spine surgery (MIS) include decreased pain, less blood loss, shorter hospital stays and faster recovery. However, there is a difficult learning curve for surgeons when mastering MIS procedures. Increasing familiarity with MIS techniques creates more options for surgeons treating spine conditions with the potential to decrease surgical complications. The goal of this conference is to update neurological and orthopedic surgeons, as well as allied health professionals on the latest advances in MIS surgical techniques.
About Nuvasive
NuVasive, Inc. (NASDAQ: NUVA) based in San Diego, California, is a medical device company focused on the design, development, and marketing of products for the surgical treatment of spine disorders. NuVasive’s product portfolio is focused on applications in the over $4.2 billion U.S. spine fusion market. The Company’s current principal product offering includes a minimally disruptive surgical platform called Maximum Access Surgery, or MAS, as well as a growing offering of cervical and motion preservation products. NuVasive® is a medical device company focused on developing minimally disruptive surgical products and procedurally integrated solutions for the spine.
The Company is the third largest medical device company in the $8.2 billion global spine market. NuVasive’s principal product offering is based on its Maximum Access Surgery, or MAS® platform. The MAS platform combines several categories of solutions that collectively minimize soft tissue disruption during spine surgery with maximum visualization and safe, easy reproducibility for the surgeon: a proprietary software-driven nerve avoidance system and intra-operative monitoring support; MaXcess®, a unique split-blade retractor system; a wide variety of specialized implants; and several biologic products to aid in the spinal fusion process. MAS significantly reduces surgery time and returns patients to activities of daily living much faster than conventional approaches.
With over 90 products today spanning lumbar, thoracic and cervical applications, the Company will continue to expand and evolve its offering predicated on its R&D focus. http://www.nuvasive.com